DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Press-release

Decision Resources Study Evaluates the Strategies of Eli Lilly and Other Depression Market Leaders to Combat Generic Competition

Decision Resources Study Evaluates the Strategies of Eli Lilly and Other Depression Market Leaders to Combat Generic Competition

Depression, a new study from Decision Resources, Inc., examines recent trends in the treatment of depression, growing generic competition within this...

READ ARTICLE

Press-release

Decision Resources Report Forecasts Substantial Market Opportunities for Therapies to Treat Hepatitis B and C Viruses

Decision Resources Report Forecasts Substantial Market Opportunities for Therapies to Treat Hepatitis B and C Viruses

The Prevention and Treatment of Select Viral Infections is a forthcoming DR Report from Decision Resources that evaluates the current and future...

READ ARTICLE

Press-release

Decision Resources Study Projects Robust Growth in the Ovarian Cancer Drug Market

Decision Resources Study Projects Robust Growth in the Ovarian Cancer Drug Market

Ovarian cancer causes more deaths each year than all other gynecological cancers combined. The number of prevalent ovarian cancer cases in the seven...

READ ARTICLE

Press-release

Decision Resources, Inc., Launches Innovative Decision Support Tool for Evaluating and Comparing Drug Development Opportunities in Central Nervous System (CNS) Disorders

Decision Resources, Inc., Launches Innovative Decision Support Tool for Evaluating and Comparing Drug Development Opportunities in Central Nervous System (CNS) Disorders

Decision Resources, Inc., today announced the availability of its new, proprietary decision support tool, COMPETITIVE LANDSCAPE ™ for CNS. Featuring...

READ ARTICLE

Press-release

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

Pharmacia and Pfizer's Celebrex and Merck's Vioxx Will Soon Compete with Second-Generation Selective COX-2 Inhibitors in the Osteoarthritis Drug Market, According to a Decision Resources Study

All eyes have been on the first selective COX-2 inhibitors, celecoxib (Pharmacia and Pfizer's Celebrex) and rofecoxib (Merck's Vioxx), for the...

READ ARTICLE

Press-release

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources Study Evaluates Type 2 Diabetes Therapies in Early- and Late-Stage Development and Forecasts Their Commercial Potential

Decision Resources, Inc., announces the publication of Type 2 Diabetes, a new study that evaluates the commercial potential of novel agents to treat...

READ ARTICLE

Press-release

Decision Resources Elects Two Vice Presidents

Decision Resources Elects Two Vice Presidents

Decision Resources, Inc., a pharmaceutical research and consulting firm, is pleased to announce the election of two new Vice Presidents-James...

READ ARTICLE

Press-release

Emerging Agents with Anticoagulant and Anti-Inflammatory Properties Promise Safe, Effective Treatments for Severe Sepsis and Septic Shock, According to a Decision Resources Study

Emerging Agents with Anticoagulant and Anti-Inflammatory Properties Promise Safe, Effective Treatments for Severe Sepsis and Septic Shock, According to a Decision Resources Study

Sepsis and septic shock are leading causes of morbidity and mortality among hospitalized patients. Sepsis and Septic Shock is a new study from...

READ ARTICLE

Press-release

Decision Resources Releases Study Illustrates How Pharmaceutical Companies Can Mine Clinical Development Programs for Strategic Product Advantages

Decision Resources Releases Study Illustrates How Pharmaceutical Companies Can Mine Clinical Development Programs for Strategic Product Advantages

Using Clinical Trials to Strategic Advantage is a new DR Report from Decision Resources, Inc., that explains how clinical trials can be invaluable...

READ ARTICLE

Press-release

Decision Resources Study Profiles 39 Companies Developing Innovative Drug Delivery Systems for Biopharmaceuticals

Decision Resources Study Profiles 39 Companies Developing Innovative Drug Delivery Systems for Biopharmaceuticals

Decision Resources, Inc., announces the publication of Emerging Delivery Systems for Biopharmaceuticals, a new DR Report that offers crucial strategic...

READ ARTICLE

Press-release

Decision Resources Report Identifies Opportunities Generated by Trends in Genomics Dealmaking

Decision Resources Report Identifies Opportunities Generated by Trends in Genomics Dealmaking

Decision Resources, Inc., announces the publication of Genomics Dealmaking in 2000 and Future Outlook: Bioinformatics, Gene Expression Monitoring,...

READ ARTICLE

Press-release

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Decision Resources Study on Post-Myocardial Infarction Finds AstraZeneca's Rosuvastatin May Become the Statin of Choice by 2005

Post-Myocardial Infarction is a new study from Decision Resources, Inc., that examines how the need for better and novel cardioprotective agents to...

READ ARTICLE